Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells

Laurie B. Hazeltine, Chelsey S. Simmons, Max R. Salick, Xiaojun Lian, Mehmet G. Badur, Wenqing Han, Stephanie M. Delgado, Tetsuro Wakatsuki, Wendy C. Crone, Beth L. Pruitt, Sean P. PalecekInternational Journal of Cell Biology 2012 · DOI

TL;DR

Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) show promise for regenerative medicine and drug discovery. This study demonstrates that hPSC-CMs exhibit a stiffness-dependent increase in contractile force, mirroring native cardiomyocytes, and respond appropriately to a common cardiac stimulant. This functional similarity suggests hPSC-CMs are a viable model for studying cardiac function and disease.

What Problem Does This Paper Address?

Cardiovascular disease is a leading cause of mortality, and current treatments like heart transplants are limited. Engineered heart tissue using cardiomyocytes derived from human pluripotent stem cells (hPSCs) offers a potential solution. However, before hPSC-CMs can be reliably used, their functionality needs to be thoroughly characterized to ensure they behave like native cardiomyocytes. A key aspect of cardiac function is the Frank-Starling Law, which describes how the heart's contractile force increases with increased demand (e.g., blood flow). This paper investigates whether singularized hPSC-CMs exhibit this crucial functional response to changes in their mechanical environment, specifically substrate stiffness, which can mimic increased cardiac demand.

Methods

The researchers employed a multi-pronged approach:

  • Polyacrylamide (PA) Hydrogel Fabrication: They created PA hydrogels with a range of stiffnesses (4.4-99.7 kPa) by varying the bisacrylamide crosslinker concentration. This range was chosen to mimic the physiological stiffness of developing, mature, and diseased heart tissue.
  • Traction Force Microscopy (TFM): Fluorescent beads were embedded in the PA hydrogels. By tracking the displacement of these beads using confocal microscopy and specialized software (LIBTRC), the researchers could quantify the forces (contraction stress) exerted by the cardiomyocytes on the substrate. This technique allows for the measurement of contractile output at the single-cell level.
  • Directed Differentiation of hPSCs: They used a well-established protocol to differentiate hPSCs (both H9 hESCs and 19-9-11 hiPSCs) into cardiomyocytes. Flow cytometry was used to confirm the purity of the differentiated cardiomyocyte populations (>90% Troponin T positive).
  • Neonatal Rat Cardiomyocyte Isolation: For comparison, they also isolated and cultured neonatal rat cardiomyocytes, which are a standard model for studying cardiac function.
  • Morphological Characterization: Immunocytochemistry for α-actinin was performed to visualize sarcomere organization, and image analysis was used to quantify cell area and eccentricity.
  • Pharmacological Stimulation: Isoprenaline, a β1-adrenoceptor agonist known to increase cardiac contractility and beating rate, was used to test the functional response of hPSC-CMs to a pharmaceutical agent.

Datasets

Not discussed in the paper. The study generated its own experimental data through cell culture, microscopy, and mechanical testing.

Key Insights and Ideas

  • Stiffness-Dependent Contractility: The most significant finding is that both hPSC-derived and neonatal rat cardiomyocytes increase their contractile stress as the stiffness of the surrounding substrate increases. This directly supports the hypothesis that singularized cardiomyocytes can exhibit a response analogous to the Frank-Starling Law.
  • Functional Similarity to Native Cells: The observed stiffness-dependent contractility in hPSC-CMs mirrors that seen in neonatal rat cardiomyocytes, suggesting a high degree of functional similarity.
  • Independence of Morphology and Beating Rate: Interestingly, neither cell morphology (size, shape) nor beating rate was found to be directly linked to substrate stiffness. This implies that the increased contractile force on stiffer substrates is a direct mechanical response rather than a consequence of changes in cell shape or how fast the cells are beating.
  • Pharmacological Responsiveness: hPSC-CMs responded to isoprenaline by increasing their beating rate, a key indicator of functional responsiveness to common cardiac stimulants.
  • Maturation Stability: The contractile stress of hPSC-CMs remained stable for up to two months post-differentiation, indicating a consistent functional output over a relevant period for potential applications.

Key Results

  • Contraction Stress: Average and maximum contraction stress of all cardiomyocyte types (neonatal rat, D30 H9, D30 19-9-11) significantly increased with substrate stiffness, ranging from 4.4 kPa to 99.7 kPa.
  • Beating Rate: Substrate stiffness did not significantly affect the beating rate of any of the cardiomyocyte types.
  • Cell Area: Cell area peaked on intermediate stiffness substrates (49.4 kPa) for D30 19-9-11-derived cardiomyocytes.
  • Cell Eccentricity: Substrate stiffness did not significantly affect cell eccentricity for most cell types, with neonatal rat cardiomyocytes showing higher eccentricity overall.
  • Isoprenaline Response: Isoprenaline significantly increased the beating rate of hPSC-CMs but did not significantly alter their average contraction stress.
  • Time Stability: Contraction stress remained stable between 30 and 60 days post-differentiation for hPSC-CMs.

Limitations and Future Work

  • Heterogeneity: The authors acknowledge that cell morphology was heterogeneous across the population, which might contribute to variability in contraction stress measurements. They suggest that microcontact printing techniques could be used to control cell size and shape, potentially reducing this variability.
  • Drug Measurement: For isoprenaline treatment, untreated and treated measurements were taken from separate populations. The authors suggest that measuring both in the same population, perhaps using a perfusion system, could provide more accurate quantification of the contractile response.
  • Maturation Stage: While hPSC-CMs showed stable contraction stress for up to two months, they likely represent an intermediate stage of maturation. Further research is needed to understand how contraction stress generation develops over longer periods and to link it to structural or functional maturation markers.
  • In Vitro vs. In Vivo: While hPSC-CMs exhibit functional similarities to native cardiomyocytes, they are cultured in 2D and may not fully replicate the complex 3D environment and electrical coupling of the native heart. Future work could explore 3D culture systems and electrical pacing to achieve more physiologically relevant beating rates.
  • Clump Size: While clumps of cardiomyocytes were observed to contract, their contraction stress was not significantly different from single cells. Further investigation into how cell-cell interactions influence contractility in larger aggregates could be beneficial.

Summary updated

Abstract

Human pluripotent stem cell (hPSC-) derived cardiomyocytes have potential applications in drug discovery, toxicity testing, developmental studies, and regenerative medicine. Before these cells can be reliably utilized, characterization of their functionality is required to establish their similarity to native cardiomyocytes. We tracked fluorescent beads embedded in 4.4-99.7 kPa polyacrylamide hydrogels beneath contracting neonatal rat cardiomyocytes and cardiomyocytes generated from hPSCs via growth-factor-induced directed differentiation to measure contractile output in response to changes in substrate mechanics. Contraction stress was determined using traction force microscopy, and morphology was characterized by immunocytochemistry for α-actinin and subsequent image analysis. We found that contraction stress of all types of cardiomyocytes increased with substrate stiffness. This effect was not linked to beating rate or morphology. We demonstrated that hPSC-derived cardiomyocyte contractility responded appropriately to isoprenaline and remained stable in culture over a period of 2 months. This study demonstrates that hPSC-derived cardiomyocytes have appropriate functional responses to substrate stiffness and to a pharmaceutical agent, which motivates their use in further applications such as drug evaluation and cardiac therapies.
BibTeX
@article{hazeltine2012effects,
  author = {Laurie B. Hazeltine and Chelsey S. Simmons and Max R. Salick and Xiaojun Lian and Mehmet G. Badur and Wenqing Han and Stephanie M. Delgado and Tetsuro Wakatsuki and Wendy C. Crone and Beth L. Pruitt and Sean P. Palecek},
  title = {{Effects of Substrate Mechanics on Contractility of Cardiomyocytes Generated from Human Pluripotent Stem Cells}},
  journal = {International Journal of Cell Biology},
  year = {2012},
  doi = {10.1155/2012/508294},
}
Figure